Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 2,583.87% vs 0.00% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 110.15% vs -259.46% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 107.50% vs -192.04% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 6,600.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Nuvation Bio, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 98.57% vs 219.85% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 2,583.87% vs 0.00% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 114.75% vs 34.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 110.15% vs -259.46% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 113.13% vs 40.07% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 107.50% vs -192.04% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 3.08% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 6,600.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






